India's Alkem Labs denies its products failed quality test

BENGALURU (Reuters) - India's Alkem Laboratories on Friday denied claims that batches of its products, Pan-D and Clavam 625, are not of standard quality as the country's drug regulator flagged, adding that those samples were fake.

India's drug regulator, which releases a monthly list of substandard or fake medicines sold in the country, said it found more than 50 drugs, including some batches of widely used antacids and paracetamol, "not of standard quality".

Alkem said it investigated the claims by comparing the Central Drugs Standard Control Organisation's samples and the actual batches of both products and found that the CDSCO's samples were not manufactured by the company.

The shares of the company slipped more than 1% before closing 0.2% lower on Friday.

(Reporting by Ashna Teresa Britto; Editing by Janane Venkatraman)